Sciclone Pharmaceuticals Inc

CIK 880771 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Sciclone Pharmaceuticals Inc.

Recent SEC filings

FiledFormAccession number
Feb 9, 2018SC 13G/A0001258897-18-001278
Nov 6, 2017EFFECT9999999995-17-002879
Nov 6, 2017EFFECT9999999995-17-002875
Nov 6, 2017EFFECT9999999995-17-002881
Nov 6, 2017EFFECT9999999995-17-002876
Nov 6, 2017EFFECT9999999995-17-002880
Nov 6, 2017EFFECT9999999995-17-002878
Nov 6, 2017EFFECT9999999995-17-002874
Nov 6, 2017EFFECT9999999995-17-002877
Nov 6, 2017EFFECT9999999995-17-002863
Nov 6, 2017EFFECT9999999995-17-002865
Oct 31, 2017S-8 POS0001193125-17-326768
Oct 31, 2017S-8 POS0001193125-17-326752
Oct 31, 2017POS AM0001193125-17-326649
Oct 31, 2017S-8 POS0001193125-17-326740
Oct 31, 2017POS AM0001193125-17-326673
Oct 31, 2017S-8 POS0001193125-17-326726
Oct 31, 2017S-8 POS0001193125-17-326746
Oct 31, 2017POS AM0001193125-17-326654
Oct 31, 2017POS AM0001193125-17-326669
Oct 31, 2017S-8 POS0001193125-17-326765
Oct 31, 2017POS AM0001193125-17-326680
Oct 31, 2017POS AM0001193125-17-326643
Oct 31, 2017S-8 POS0001193125-17-326735
Oct 31, 2017POS AM0001193125-17-326646